Skip to main content
. 2020 Mar 15;11(12):3567–3579. doi: 10.7150/jca.43518

Table 2.

Multivariate analyses of cancer-specific survival in patients with SPT.


Characteristic
All patients Derivation set
No. of patient (n=25983) HR (95% CI) P No. of patient (n=18175) HR (95% CI) P
Age <0.001 <0.001
≤65 13740 1 9545 1
>65 12243 1.061 (1.029, 1.093) 8630 1.341 (1.293, 1.389)
Gender 0.738 0.189
Male 13155 1 9177 1
Female 12898 0.995 (0.967, 1.024) 8998 0.977 (0.944, 1.011)
Race 0.083 <0.001
White 19868 1 13948 1
Black 3945 1.034 (0.993, 1.077) 2689 1.095 (1.043, 1.149)
Other 2170 0.965 (0.915, 1.018) 1538 0.932 (0.875, 0.993 )
Site 0.004 <0.001
Left 9552 1 6679 1
Right 16431 1.047 (1.015,1.080) 11496 1.245 (1.199, 1.291)
Grade <0.001 <0.001
Grade I/II 17146 1 11945 1
Grade III/IV 8837 1.070 (1.038, 1.104) 6230 1.378 (1.328, 1.429)
T stage 0.001 <0001
T1/T2 896 1 634 1
T3/T4 25087 1.150 (1.055, 1.254) 17541 1.475 (1.332, 1.633)
N examined <0.001 <0.001
0-6 2658 1 1844 1
7-12 6015 0.927 (0.880, 0.977) 4192 0.848 (0.797, 0.903)
13-18 8156 0.831 (0.790, 0.874) 5748 0.685 (0.645, 0.728)
19-24 4425 0.776 (0.733, 0.821) 3094 0.602(0.563, 0.644)
>24 4729 0.747(0.706, 0.790) 3297 0.538 (0.503,0.575)
N positive <0.001 <0.001
1-3 7782 1 5421 1
4-6 5264 1.083 (1.039, 1.128) 3734 1.205 (1.147, 1.266)
7-9 3154 1.132 (1.078, 1.188) 2233 1.400 (1.321, 1.483)
10-12 1926 1.192 (1.126, 1.263) 1334 1.754 (1.637, 1.879)
>12 3420 1.251 (1.192, 1.313) 2375 1.914 (1.806, 2.028)
0 4437 0.871(0.831, 0.913) 3078 0.723 (0.684, 0.765)
Chemotherapy <0.001
Yes 16294 1 <0.001 11394 1
No/NA 9689 1.116 (1.083, 1.151) 6781 2.140 (2.064, 2.220)

Left: descending colon and sigmoid colon; Right: cecum, ascending colon, hepatic flexure, transverse colon and splenic flexure; N: lymph node; NA: not available.